Ads
related to: acute myeloid leukemia in remission- Testing For AML
Learn About The Importance of
Testing For Mutations in AML.
- AML Treatment Option
See If an AML Treatment Option
May Be Able To Help Your Patients.
- Physician Resources
Access Support & Resources On
The Official Physician Website.
- Clinical Recommendations
Info On a Treatment Recommendation
From An AML Treatment Guideline.
- View Dosing Guidelines
Clinical Dosing Guidelines For
an AML Treatment Option.
- View The Clinical Data
Explore The Clinical Data
For an AML Treatment Option.
- Testing For AML
cancer.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
"7+3" in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today (as of 2014) as first-line induction therapy (to induce remission) in acute myelogenous leukemia, [1] [2] excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy (if requires it at all, which is not always ...
Acute myeloid leukemia is a very heterogeneous disease, composed of a variety of translocations and mutations. However, one tenth of all acute myeloid leukemia cases diagnosed have the AML1-ETO fusion oncoprotein due to the t(8;21) translocation. AML1 or RUNX1 is a DNA-binding transcription factor located at the 21q22.
Transient myeloid leukemia is a pre-leukemic condition. [30] [31] [32] Clonal hematopoiesis is a common age-related phenomenon with a low risk of progression to myelodysplastic syndrome (MDS) and leukemia. [33] Once MDS has developed, the risk of progression to acute leukemia can be assessed using the International Prognostic Scoring System .
MRD was originally described in hematological cancers such as adult acute myeloid leukemia. [5] [6] Subsequently MRD research has broadened out to other hematological malignancies such as Multiple Myeloma, [7] as well as to solid tumors.
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid , of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
Ads
related to: acute myeloid leukemia in remission